Deep sncRNA-seq of the PPMI cohort to study Parkinson's disease progression [article]

Fabian Kern, Tobias Fehlmann, Ivo Violich, Eric Alsop, Elizabeth Hutchins, Mustafa Kahraman, Nadja Liddy Grammes, Pedro Guimaraes, Christina Backes, Kathleen Poston, Bradford Casey, Rudi Balling (+9 others)
2020 biorxiv/medrxiv   pre-print
Coding and non-coding RNAs have diagnostic and prognostic importance in Parkinson's diseases (PD). We studied circulating small non-coding RNAs (sncRNAs) in 7,003 samples from two longitudinal PD cohorts (Parkinson's Progression Marker Initiative (PPMI) and Luxembourg Parkinson's Study (NCER-PD)) and modelled their influence on the transcriptome. First, we sequenced sncRNAs in 5,450 blood samples of 1,614 individuals in PPMI. The majority of 323 billion reads (59 million reads per sample)
more » ... to miRNAs. Other covered RNA classes include piRNAs, rRNAs, snoRNAs, tRNAs, scaRNAs, and snRNAs. De-regulated miRNAs were associated with the disease and disease progression and occur in two distinct waves in the third and seventh decade of live. Originating mostly from a characteristic set of immune cells they resemble a systemic inflammation response and mitochondrial dysfunction, two hallmarks of PD. By profiling 1,553 samples from 1,024 individuals in the NCER-PD cohort using an independent technology, we validate relevant findings from the sequencing study. Finally, network analysis of sncRNAs and transcriptome sequencing of the original cohort identified regulatory modules emerging in progressing PD patients.
doi:10.1101/2020.06.01.127092 fatcat:ykt66kdjszhahgavkqw3inu2a4